[go: up one dir, main page]

WO1992008731A3 - Molecule d'adhesion t-cadherine - Google Patents

Molecule d'adhesion t-cadherine Download PDF

Info

Publication number
WO1992008731A3
WO1992008731A3 PCT/US1991/008022 US9108022W WO9208731A3 WO 1992008731 A3 WO1992008731 A3 WO 1992008731A3 US 9108022 W US9108022 W US 9108022W WO 9208731 A3 WO9208731 A3 WO 9208731A3
Authority
WO
WIPO (PCT)
Prior art keywords
cadherin
various forms
tumor cell
polypeptides
adhesion molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1991/008022
Other languages
English (en)
Other versions
WO1992008731A2 (fr
Inventor
Barbara Ranscht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanford Burnham Prebys Medical Discovery Institute
Original Assignee
Sanford Burnham Prebys Medical Discovery Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanford Burnham Prebys Medical Discovery Institute filed Critical Sanford Burnham Prebys Medical Discovery Institute
Priority to AU89531/91A priority Critical patent/AU669474B2/en
Priority to JP4500867A priority patent/JPH06505962A/ja
Priority to EP92900808A priority patent/EP0619841B1/fr
Priority to DE69129760T priority patent/DE69129760T2/de
Publication of WO1992008731A2 publication Critical patent/WO1992008731A2/fr
Publication of WO1992008731A3 publication Critical patent/WO1992008731A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des polypeptides de T-cadherine purifiés ainsi que des acides nucléiques isolés codant les polypeptides de T-cadherine. L'invention concerne également des anticorps réagissant avec diverses formes de T-cadherine, mais ne réagissant pas avec la N-, E- ou P-cadherine. L'invention concerne des procédés de détection des diverses formes de T-cadherine chez un sujet ainsi qu'un procédé d'inhibition de migration de cellules tumorales consistant à augmenter l'adhésion des cellules tumorales à l'aide d'une dose efficace de T-cadherine. En outre, l'invention concerne un procédé de réparation de neurones ayant subi des traumatismes. Le procédé consiste à traiter des neurones ayant subi des traumatismes avec une dose thérapeutiquement efficace de T-cadherine.
PCT/US1991/008022 1990-10-30 1991-10-30 Molecule d'adhesion t-cadherine Ceased WO1992008731A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU89531/91A AU669474B2 (en) 1990-10-30 1991-10-30 T-cadherin adhesion molecule
JP4500867A JPH06505962A (ja) 1990-10-30 1991-10-30 Ｔ−カドヘリン接着分子
EP92900808A EP0619841B1 (fr) 1990-10-30 1991-10-30 Molecule d'adhesion t-cadherine
DE69129760T DE69129760T2 (de) 1990-10-30 1991-10-30 T-cadherin-bindungsmolekül

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60729390A 1990-10-30 1990-10-30
US607,293 1990-10-30

Publications (2)

Publication Number Publication Date
WO1992008731A2 WO1992008731A2 (fr) 1992-05-29
WO1992008731A3 true WO1992008731A3 (fr) 1992-06-25

Family

ID=24431648

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1991/008022 Ceased WO1992008731A2 (fr) 1990-10-30 1991-10-30 Molecule d'adhesion t-cadherine

Country Status (8)

Country Link
US (4) US5585351A (fr)
EP (1) EP0619841B1 (fr)
JP (1) JPH06505962A (fr)
AT (1) ATE168131T1 (fr)
AU (1) AU669474B2 (fr)
CA (1) CA2095115A1 (fr)
DE (1) DE69129760T2 (fr)
WO (1) WO1992008731A2 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE168131T1 (de) * 1990-10-30 1998-07-15 Jolla Cancer Res Found T-cadherin-bindungsmolekül
EP2325203A2 (fr) 1992-04-17 2011-05-25 Doheny Eye Institute Eléments et procédés permettant la production de cadherines
US5646250A (en) * 1992-04-17 1997-07-08 Doheny Eye Institute Cadherin polypeptides
US5597725A (en) * 1992-04-17 1997-01-28 Doheny Eye Institute Cadherin-specific antibodies and hybridoma cell lines
US5798224A (en) * 1992-12-29 1998-08-25 Doheny Eye Institute Nucleic acids encoding protocadherin
US5643781A (en) * 1992-12-29 1997-07-01 Doheny Eye Institute DNA encoding protocadherin-42
AU722985B2 (en) 1996-07-12 2000-08-17 Mcgill University Compounds and methods for modulating cell adhesion
US6610821B1 (en) 1996-07-12 2003-08-26 Mcgill University Compounds and methods for modulating endothelial cell adhesion
US20040006011A1 (en) * 1996-07-12 2004-01-08 Gour Barbara J. Peptidomimetic modulators of cell adhesion
US6346512B1 (en) 1996-07-12 2002-02-12 Mcgill University Compounds and methods for modulating cell adhesion
US6417325B1 (en) 1996-07-12 2002-07-09 Mcgill University Compounds and methods for cancer therapy
US6333307B1 (en) 1996-07-12 2001-12-25 Mcgill University Compounds and method for modulating neurite outgrowth
US6207639B1 (en) 1996-07-12 2001-03-27 Mcgill University Compounds and methods for modulating neurite outgrowth
US6562786B1 (en) 1996-07-12 2003-05-13 Mcgill University Compounds and methods for modulating apoptosis
US7122623B2 (en) 1996-07-12 2006-10-17 Adherex Technologies, Inc. Compounds and methods for modulating cell adhesion
US6169071B1 (en) 1996-07-12 2001-01-02 Mcgill University Compounds and methods for modulating cell adhesion
US6465427B1 (en) 1996-07-12 2002-10-15 Mcgill University Compounds and methods for modulating cell adhesion
US6203788B1 (en) 1997-09-29 2001-03-20 Adherex Inc. Compounds and methods for regulating cell adhesion
US6638911B1 (en) 1998-05-05 2003-10-28 Adherex Technologies Inc. Compounds and methods for modulating desmosomal cadherin-mediated functions
US20050203025A1 (en) * 1998-05-05 2005-09-15 Adherex Technologies, Inc. Compounds and methods for modulating nonclassical cadherin-mediated functions
US7481999B2 (en) * 1998-05-05 2009-01-27 Adherex Technologies, Inc. Compounds and methods for modulating OB-cadherin-mediated function
US6680175B2 (en) * 1998-05-05 2004-01-20 Adherex Technologies, Inc. Methods for diagnosing and evaluating cancer
US6472367B1 (en) 1998-05-05 2002-10-29 Adherex Technologies, Inc. Compounds and methods for modulating OB-cadherin mediated cell adhesion
US6277824B1 (en) * 1998-07-10 2001-08-21 Adherex Technologies Compounds and methods for modulating adhesion molecule function
US7041807B1 (en) 1999-06-23 2006-05-09 Caprion Pharmaceuticals, Inc. Antibodies to a YYX epitope of a mammalian prion protein
US20030054985A1 (en) * 2000-02-22 2003-03-20 Stuart Aaronson N-cadherin modulated migration, invasion, and metastasis
US20040072236A1 (en) 2002-09-27 2004-04-15 Neil Cashman PrPSc -interacting molecules and uses thereof
US7476509B2 (en) * 2002-11-14 2009-01-13 Adherex Technologies Inc. Compounds and methods for modulating functions of nonclassical cadherins
EP1627229A2 (fr) * 2003-04-29 2006-02-22 Cytos Biotechnology AG Procedes et compositions pour la modulation de l'interaction entre l'adiponectine et son recepteur
WO2006045849A1 (fr) * 2004-10-29 2006-05-04 Cytos Biotechnology Ag Reseaux d'antigenes de la t-cadherine et utilisations
EP2444421A1 (fr) * 2005-04-26 2012-04-25 Pfizer Inc. Anticorps de la P-Cadherine
US20060292159A1 (en) * 2005-06-08 2006-12-28 Ranscht Barbara E Methods for the inhibition of neovascularization and cancer metastasis
US9534058B2 (en) 2012-02-08 2017-01-03 Abbvie Stemcentrx Llc Anti-CD324 monoclonal antibodies and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE168131T1 (de) * 1990-10-30 1998-07-15 Jolla Cancer Res Found T-cadherin-bindungsmolekül

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Ann. Rev. Biochem, Volume 59, issued 1990, M. TAKEICHI et al.: "Cadherins: A Molecular Family Important in Selective Cell-Cell Adhesion", pages 237-252. *
Nature, Volume 227, issued 15 August 1970, U.K. LAEMMLI, "Cleavage of Structural Proteins During the Assembly of the Head of Bacteriophage T4", pages 680-685, see the entire document, particularly the Abstract at page 680. *
The Journal of Cell Biology, Volume 106, issued March 1988, K. HATTA et al., "Cloning and Expression of cDNA Encoding a Neural Calcium-dependent Cell Adhesion Molecule: Its Identity in the Cadherin Gene Family", pages 873-881, see the Abstract at page 873. *
The Journal of Cell Biology, Volume 99, issued November 1984, B. RANSCHT et al., "A Neuronal Surface Glycoprotein Associated with the Cytoskeleton", pages 1803-1813, see the entire document, particularly the Abstract at page 1803. *

Also Published As

Publication number Publication date
US5811518A (en) 1998-09-22
ATE168131T1 (de) 1998-07-15
DE69129760T2 (de) 1999-03-25
AU669474B2 (en) 1996-06-13
EP0619841A1 (fr) 1994-10-19
EP0619841A4 (fr) 1994-05-17
CA2095115A1 (fr) 1992-05-01
US5837525A (en) 1998-11-17
AU8953191A (en) 1992-06-11
EP0619841B1 (fr) 1998-07-08
JPH06505962A (ja) 1994-07-07
DE69129760D1 (de) 1998-08-13
WO1992008731A2 (fr) 1992-05-29
US5863804A (en) 1999-01-26
US5585351A (en) 1996-12-17

Similar Documents

Publication Publication Date Title
WO1992008731A3 (fr) Molecule d'adhesion t-cadherine
GB2133408B (en) Method for improving the production of proteins in bacillus
DE69624503D1 (de) Verfahren zum verleihen von schlagzähigkeit an eine kunststoff-ophthalmische linse und damit hergestellte linse
NO971523D0 (no) Stålrörforbindelse med höy rivingsmotstand, samt fremgangsmåte for overflatebehandling av denne
EP0652053A3 (fr) Méthode et dispositif pour appliquer des matériaux de couche primaire sur des éléments en verre d'automobiles.
WO1996009386A3 (fr) Variantes alleliques du recepteur 5ht2c de la serotonine
AU4234389A (en) Method for the reduction of heterogeneity of monoclonal antibodies
EP1013762A3 (fr) Gène du type delta exprimé dans des tumeurs neuro-endocriniennes
AU587812B2 (en) Amorphous silicon photoreceptors for electrophotography, process for the preparation and/or regeneration thereof, and method for the electrophotography using such materials
AU2527284A (en) Urea linked immunogens, antibodies and preparative method
DE69625024D1 (de) Verfahren zum Nachweis von Protein im Harn
FI884319A7 (fi) Menetelmä vaikeasti lohkaistavien aromaattien lohkaisemiseksi saastuneissa pohjissa tai deponointiaineissa mikro-organismeilla.
AU7156381A (en) Method and apparatus for running and cementing pipe
FR2693209B1 (fr) Procédé de détermination de la taille en nucléotides de fragments d'ADN.
BR9709721A (pt) Polinucleotídeo purificado e isolado dna vetor célula hospedeira processo para prodzir quitanase humama para tratar uma infecção fúngica e para reduzir a quantidade de um ant-fúngico não-quitanase fragmento de polipeptídeo de quitanase humama linha de células de hiridoma anticorpo monoclonal e composição farmacéutica
PT77701B (en) Improved system for coating welded pipe joints with weighting material
WO1996023884A3 (fr) Recepteurs humains actives par les proliferateurs du peroxisome
AU6189096A (en) Heterologous polypeptide production in the absence of nonsense-mediated mRNA decay function
DE3561242D1 (en) Peroxycarbonate group-containing copolymer and method for manufacture thereof
ATE83262T1 (de) Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega.
IL72924A0 (en) Preparations for use in solid phase immunoassays comprising monoclonal antibodies covalently embedded in their immobilized hybridoma cells
CA2092830A1 (fr) Methode de protection contre la corrosion et appareil connexe
BR9606557A (pt) Anticorpo monoclonal hibridoma polipeptídeo purificado e isolado polinucleotídeo purificado e isolado DNA célula hospedeira e método para produzir o polipeptídeo
FR2713397B1 (fr) Procédé de formation de couches métalliques minces et épaisses.
AU7071481A (en) Process for tack coating in road surfacing

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AT AU BB BG BR CA CH CS DE DK ES FI GB HU JP KP KR LK LU MC MG MN MW NL NO PL RO SD SE SU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU ML MR NL SE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AT AU BB BG BR CA CH CS DE DK ES FI GB HU JP KP KR LK LU MC MG MN MW NL NO PL RO SD SE SU

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU ML MR NL SE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2095115

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1992900808

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1992900808

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1992900808

Country of ref document: EP